INSMED Inc. Files 8-K on Financials

Ticker: INSM · Form: 8-K · Filed: 2025-10-30T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, sec-filing

TL;DR

INSMED filed an 8-K on Oct 30, 2025, updating on financial condition. Details to follow.

AI Summary

On October 30, 2025, INSMED Incorporated filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were provided in the excerpt.

Why It Matters

This filing indicates INSMED Inc. is providing updates on its financial performance and condition to the SEC, which is crucial for investors to assess the company's health.

Risk Assessment

Risk Level: low — This is a routine filing of financial information and does not inherently present new risks.

Key Players & Entities

FAQ

What specific financial results or conditions are being reported by INSMED Inc. in this 8-K?

The provided excerpt does not contain specific financial results or details about the conditions being reported, only that the filing pertains to 'Results of Operations and Financial Condition'.

What is the primary purpose of this 8-K filing for INSMED Inc.?

The primary purpose is to report on INSMED Inc.'s Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.

When was this 8-K filing submitted?

The filing was submitted on October 30, 2025.

What is INSMED Inc.'s principal executive office address?

INSMED Inc.'s principal executive offices are located at 700 US Highway 202/206, Bridgewater, New Jersey 08807.

Under which section of the Securities Exchange Act of 1934 is this report filed?

This report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.

Filing Stats: 540 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2025-10-30 07:00:36

Key Financial Figures

Filing Documents

02 — Results of Operations and Financial Condition

ITEM 2.02 — Results of Operations and Financial Condition. On October 30, 2025, Insmed Incorporated (the "Company") issued a press release regarding its financial results for the third quarter ended September 30, 2025. A copy of this press release is furnished herewith as Exhibit 99.1 pursuant to this Item 2.02 and is incorporated herein by reference. The slide presentation to be used during the conference call referenced in the press release is furnished herewith as Exhibit 99.2. The information contained herein, including Exhibits 99.1 and 99.2 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01 – Financial Statements and Exhibits

ITEM 9.01 – Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Insmed Incorporated on October 30, 2025. 99.2 Insmed Incorporated October 30, 2025 Presentation. 104 Cover Page Interactive Date File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 30, 2025 INSMED INCORPORATED By: /s/ Michael A. Smith Name: Michael A. Smith Title: Chief Legal Officer and Corporate Secretary

View on Read The Filing